labetalol has been researched along with Adenomatosis, Familial Endocrine in 1 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
Excerpt | Relevance | Reference |
---|---|---|
"Oral prazosin was started twenty days before the operation and increased to a maintenance dose of 6 mg per day." | 1.28 | [Anesthetic management of a patient with Sipple syndrome]. ( Ishizaki, A; Kim, S; Matsukawa, M; Shiratsuchi, T; Uchiyama, M; Yamamoto, T, 1991) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishizaki, A | 1 |
Kim, S | 1 |
Shiratsuchi, T | 1 |
Matsukawa, M | 1 |
Uchiyama, M | 1 |
Yamamoto, T | 1 |
1 other study available for labetalol and Adenomatosis, Familial Endocrine
Article | Year |
---|---|
[Anesthetic management of a patient with Sipple syndrome].
Topics: Administration, Oral; Adult; Anesthesia, Inhalation; Humans; Labetalol; Male; Multiple Endocrine Neo | 1991 |